IP Library Assignment 038215/0748
Patent Assignment
Reel/Frame 038215/0748

Certificate of Change of the Company's Address

Recorded: 2016-03-22 Pages: 2
Assignor
OHR PHARMACEUTICAL, INC.
Executed: 2014-11-14
Assignee
OHR PHARMACEUTICAL, INC.
800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties (2)
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Patent: 8,716,270 →
Application: 13/166,911 →
Publication: US 2012/0022035
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Patent: 7,981,876 →
Application: 11/410,098 →
Publication: US 2007/0010504
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 19, 2006
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 018283/0136 →
Assignment of Assignor's Interest May 9, 2011
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 026246/0796 →
Liquidating Trust Agreement Mar 16, 2012
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 027874/0365 →
Assignment of Assignor's Interest Jan 28, 2015
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 034836/0672 →
Assignment of Assignor's Interest Jan 28, 2015
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 034836/0690 →
Liquidating Trust Agreement Jan 28, 2015
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 034838/0844 →
Assignment of Assignor's Interest May 10, 2018
From: OHR PHARMACEUTICAL, INC.
To: ENTERIN, INC.
Reel/Frame 045764/0322 →